Search clinical trials for: hepatic biological parameters

Total 11866 results

Cttq

Unknown

Magnesium Isoglycyrrhizinate Followed by Diammonium Glycyrrhizinate and Combined With Entecavir in Chronic Hepatitis B (MAGIC-101)

Chronic Hepatitis b | Liver Inflammation
Hospices Civils de Lyon

Not yet recruiting

Intra-Hepatic Microbiota in Alcoholic Hepatitis (HepMAH)

Cirrhosis | Alcoholic Liver Disease | Alcoholic Hepatitis
Medical University of Warsaw
University College, London; Queen Mary University of London; National Science...

Recruiting

Comprehensive Assessment of Morphometric, Functional, Biomechanical and Biological Interactions Between Atherosclerotic Plaque and Platelets Within the Stenosed Coronary Artery (INTERFORCE)

Atherosclerosis | Chronic Coronary Syndrome

Poland
CerbaXpert

Not yet recruiting

Collection of Additional Biological Samples From Potentially COVID-19 Patients for Monitoring of Biological Parameters Carried Out as Part of the Routine (CEB Covid-19)

SARS CoV 2 Infection
University Medicine Greifswald

Not yet recruiting

Dose-dependent Kinetics of Thiamin in Healthy Volunteers With and Without Functional OCT1 Hepatic Transporters (THIAMO-1)

Healthy

Germany
Hunter Holmes Mcguire Veteran Affairs Medical Center
Grifols Biologicals, LLC

Recruiting

Hepatic Encephalopathy and Albumin Lasting Cognitive Improvement (HEAL-LAST)

Hepatic Encephalopathy | Cirrhosis

United States
University Hospital Center of Martinique
University Hospital, Limoges; Reims University Hospital; BioGaia AB; Regional Health... and other collaborators

Not yet recruiting

Effects of Probiotic Oral Intake on Plasma Chlordecone (Kepone) Concentrations in Individuals Environmentally Exposed to Pesticide in Martinique. (CHLOR-DETOX)

Chlordecone (Kepone) Toxicity

Martinique
Institut Claudius Regaud

Recruiting

Study for Characterisation of Predictive Parameters of Clonal Evolution in Subjects With GATA2 Germline Mutation (GATA-2)

GATA2 Gene Mutation

France
University of Southern California
National Cancer Institute (NCI); Auransa, Inc.

Recruiting

AU409 for the Treatment of Advanced Primary Liver Cancers or Solid Tumor With Liver Metastatic Disease

Advanced Malignant Solid Neoplasm | Refractory Malignant Solid Neoplasm | Advanced Hepatocellular Carcinoma | Metastatic Malignant Neoplasm in the Liver | Stage III Hepatocellular Carcinoma AJCC v8 | Stage IV Hepatocellular Carcinoma AJCC v8 | Advanced Cholangiocarcinoma

United States
Shanghai Eye Disease Prevention and Treatment Center

Recruiting

Study on the Effect of Two Ways of Cycloplegia on Biological Parameters of Ciliary Muscle

Refractive Errors | Myopia | Accomodation | Cycloplegia

China
Assistance Publique Hopitaux De Marseille

Recruiting

Ovarian Reserve and Semen Parameters Evolution During Adjuvant Therapy in Melanoma (MELpreserv)

Melanoma

France
Ping Liang

Recruiting

Clinical Decision Biological Biomarker and Prognosis Prediction of Hepatocellular Carcinoma by Deep Learning

Hepatocellular Carcinoma | Surgery | Ablation | Prognosis | Contrast-enhanced Ultrasound

China
Zhongnan Hospital

Recruiting

Noninvasive and Dynamic Monitoring the Biological Parameters of Eyes in Different Age Groups

Myopia

China
University of Manchester
The Christie NHS Foundation Trust

Recruiting

MR-BIO: A Study to Evaluate Changes in MR Imaging and Biological Parameters (MR-BIO)

Cancer

United Kingdom
Mayo Clinic

Recruiting

Detection of Plasma DNA Methylation in Peripheral Blood From Patients With Resectable Liver Cancer

Resectable Hepatocellular Carcinoma

United States
Children's Oncology Group
National Cancer Institute (NCI)

Recruiting

Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors

Melanoma | Neuroblastoma | Pancreatic Ductal Adenocarcinoma | Refractory Malignant Solid Neoplasm | Endometrial Carcinoma | Recurrent Ewing Sarcoma | Recurrent Hepatoblastoma | Recurrent Malignant Solid Neoplasm | Recurrent Non-Hodgkin Lymphoma | Recurrent Osteosarcoma | Refractory Ewing Sarcoma | Refractory... and other conditions

United States
IHU Strasbourg

Recruiting

Risk Stratification of Hepatocarcinogenesis Using a Deep Learning Based Clinical, Biological and Ultrasound Model in High-risk Patients (STARHE)

Hepatocellular Carcinoma | Chronic Liver Disease

France
Sun Yat-sen University

Recruiting

CT Perfusion Parameters Predict Vascular Pattern in Hepatocellular Carcinoma

Hepatocellular Carcinoma

China
University College, London

Recruiting

Analysis of Screen-detected Lung Cancers' Genomic Traits (ASCENT)

Lung Cancer

United Kingdom
University Hospital, Basel, Switzerland
Swiss National Science Foundation

Recruiting

MERTK Signalling in Monocytes/Macrophages in Patients With Liver Disease

Liver Failure | Acute-On-Chronic Liver Failure | Liver Disease | Cirrhosis of the Liver

Switzerland, United Kingdom
Assistance Publique - Hôpitaux de Paris
Institut National de la Santé Et de la Recherche Médicale, France; Etablissement... and other collaborators

Recruiting

Biological Parameters Changes After Autologous Blood Transfusion of Red Blood Cells (200 ml) in Healthy Volunteers. (AUTOT-SPORT)

The Focus is on the Detection of the Consequences of Autologous Blood Transfusion in Healthy Volunteers

France
Hospital Sirio-Libanes

Recruiting

Determination of Autonomic Responses to the Exposure of Low Energy Electromagnetic Fields With Frequency Modulation in Patients With Advanced Hepatocellular Carcinoma and Healthy Individuals.

Hepatocellular Carcinoma

Brazil
Centre Hospitalier Universitaire de Besancon

Recruiting

Study of Genetic and Cellular Immunological Parameters Predictive of Disease-free Survival in Patients With Metastatic Cancer (Epitopes-CRC01)

Metastatic Cancer

France
University of Edinburgh
NHS Lothian

Not yet recruiting

Biomarkers in Liver Failure

Acute on Chronic Hepatic Failure | Acute Liver Failure | Acute Liver Injury
National Taiwan University Hospital
Far Eastern Memorial Hospital

Not yet recruiting

MiRNA as a Diagnostic and Prognostic Biomarker of Hepatocellular Carcinoma

Carcinoma, Hepatocellular | Marker, Biological

Taiwan
Institut Paoli-Calmettes

Recruiting

Predictive Clinical and Biological Parameters in Acute Leukemia, Myelodysplastic Syndromes and Myeloproliferative Disorders-HEMATO-BIO-IPC-2013-015 (HEMATO-BIO)

Myelodysplastic Syndromes | Myeloproliferative Disorders | Acute Leukemia

France
Institut Paoli-Calmettes

Recruiting

Predictive Clinical and Biological Parameters in Gynecological Cancer (GC-BIO)

Ovarian Cancer | Cervix Cancer | Endometrium Cancer

France
Institut Paoli-Calmettes

Recruiting

Predictive Clinical and Biological Parameters in Breast Cancer (BC-BIO)

Breast Cancer

France
National Cancer Institute (NCI)

Active, not recruiting

A Study to Determine Whether Chemotherapy and Atezolizumab is Better Than Chemotherapy, Bevacizumab and Atezolizumab in Patients With Advanced Liver Cancer

Combined Hepatocellular Carcinoma and Cholangiocarcinoma | Stage III Liver Cancer | Stage IV Liver Cancer

United States
National Cancer Institute (NCI)

Suspended

Biospecimen Collection in Identifying Genetic Changes in Patients With Breast, Prostate, Colorectal, Liver, or Kidney Cancer or Multiple Myeloma Undergoing Surgery

Malignant Solid Neoplasm | Multiple Myeloma | Breast Carcinoma | Colon Carcinoma | Kidney Carcinoma | Prostate Carcinoma | Liver Carcinoma | Invasive Carcinoma

United States
National Cancer Institute (NCI)

Active, not recruiting

Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)

Glioma | Hematopoietic and Lymphoid Cell Neoplasm | Melanoma | Lymphoma | Multiple Myeloma | Recurrent Ovarian Carcinoma | Breast Carcinoma | Recurrent Head and Neck Carcinoma | Recurrent Lung Carcinoma | Recurrent Skin Carcinoma | Gastric Carcinoma | Advanced Lymphoma | Advanced Malignant Solid Neoplasm | Refractory... and other conditions

United States, Puerto Rico, Guam
National Cancer Institute (NCI)

Active, not recruiting

Testing A New Combination of Anti-cancer Immune Therapies, Atezolizumab and CDX-1127 (Varlilumab) With or Without the Addition of a Third Anti-cancer Drug, Cobimetinib, for Advanced-Stage Biliary Tract Cancer

Recurrent Gallbladder Carcinoma | Metastatic Gallbladder Carcinoma | Stage IV Gallbladder Cancer AJCC v8 | Stage IV Intrahepatic Cholangiocarcinoma AJCC v8 | Stage IV Distal Bile Duct Cancer AJCC v8 | Metastatic Intrahepatic Cholangiocarcinoma | Recurrent Intrahepatic Cholangiocarcinoma | Metastatic... and other conditions

United States
National Cancer Institute (NCI)

Active, not recruiting

Testing Maintenance Therapy for Small Cell Lung Cancer in Patients With SLFN11 Positive Biomarker

Extensive Stage Lung Small Cell Carcinoma

United States
National Cancer Institute (NCI)

Active, not recruiting

Testing the Combination of the Anti-cancer Drugs XL184 (Cabozantinib) and Nivolumab in Patients With Advanced Cancer and HIV

HIV Infection | Metastatic Renal Cell Carcinoma | Anatomic Stage III Breast Cancer AJCC v8 | Recurrent Ovarian Carcinoma | Metastatic Lung Non-Small Cell Carcinoma | Anatomic Stage IV Breast Cancer AJCC v8 | Metastatic Melanoma | Recurrent Head and Neck Carcinoma | Recurrent Renal Cell Carcinoma | Advanced... and other conditions

United States
Medical College of Wisconsin
Radiological Society of North America

Active, not recruiting

Evaluation of Hemodynamic Parameters Following Transjugular Intrahepatic Portosystemic Shunt (TIPS)

Refractory Ascites

United States
Hoffmann-La Roche

Active, not recruiting

A Study of Atezolizumab Plus Bevacizumab Versus Active Surveillance as Adjuvant Therapy in Patients With Hepatocellular Carcinoma at High Risk of Recurrence After Surgical Resection or Ablation (IMbrave050)

Carcinoma, Hepatocellular

United States, Korea, Republic of, Belgium, China, Japan, Brazil, Italy, Spain, Thailand, Australia, Costa Rica, Austria, France, Singapore, Taiwan, New Zealand, Canada, Germany, Hong Kong, Peru, Mexico, Netherlands, Czechia, Turkey, Po... and more
Tongji University
Shanghai Pharmaceuticals Holding Co., Ltd

Active, not recruiting

B010-A Injection for Treating Patients With GPC3 Positive Advanced Hepatocellular Carcinoma

Advanced Hepatocellular Carcinoma

China
Hôpital Européen Marseille

Withdrawn

Effect of Plasmapheresis on Clinical Improvement and Biological Parameters of Patients With Long-haul COVID (PLEXCOVIL)

Long-Haul COVID-19

France
Centre Hospitalier Universitaire, Amiens

Withdrawn

Influence of Verticalization on Bone Mineral Density and Biological Parameters of Bone Remodeling in Children With Severe Cerebral Palsy (CPABONE)

Cerebral Palsy | Osteoporosis | Bone Mineral Density | Fracture | Bone Remodeling Disorder

France
Centre Hospitalier Universitaire de Besancon

Completed

Study of Predictive Immunological Parameters of Molecular Complete Remission in Patients With Chronic Myelogenous Leukemia in Chronic Phase and Treated With Tyrosine Kinase Inhibitor (PAMIR01)

Chronic Leukemia

France
Groupe Hospitalier Pitie-Salpetriere

Completed

Joint Use of Electrocardiogram and Transthoracic Echocardiography With Other Clinico-biological Parameters in an Observational Study to Monitor Cardio-vascular Events and Predict Outcomes in Patients Diagnosed With COVID-19 (JOCOVID)

COVID-19 | Myocardial Injury | Myocarditis

France
Centre Hospitalier Universitaire Dijon

Completed

Venous Congestion and Organ Dysfunction. (CoDoRéa)

Venous Congestion | Organ Dysfunction Syndrome

France
Genfit

Completed

Nitazoxanide Pharmacokinetic Parameters in Hepatic Impaired Patients

Liver Diseases | Moderate Hepatic Impairment | Severe Hepatic Impairment

United States
University Hospital, Clermont-Ferrand

Terminated

Paracetamol and Neuropathic Pain (PAeoNy)

Neuropathic Pain

France
Azienda Ospedaliero-Universitaria Consorziale Policlinico...
Catholic University of the Sacred Heart; Institute of Biomembranes, Bioenergetics... and other collaborators

Completed

Establishment of the Human Intestinal and Salivary Microbiota Biobank - Gastrointestinal Diseases (BIOMIS-Gastr)

Hepatic Encephalopathy | Irritable Bowel Syndrome | Clostridium Difficile Infection | Chronic Inflammatory Bowel Disease | Multi Drug Resistant Organisms

Italy
Groupe Hospitalier Paris Saint Joseph
ObvioHealth

Completed

Prospective Cohort Study to Describe the Clinical Characteristics of COVID-19, the Acquired Immune Response and the Biological and Clinical Parameters of Patients Followed in Oncology by the Saint-Joseph Hospital Group for a Period of 6 Months During the COVID-19 Pandemic (OBVIONCO)

COVID-19 | Oncology

France
University Hospital, Grenoble

Completed

19/5000 (SYNAPSOT21) Predictive Factors of Sleep Apnea Syndrome in Down Syndrome (SYNAPSOT21)

Sleep Apnea, Obstructive | Down Syndrome | Polysomnography

France
Nantes University Hospital

Completed

Relevance of Plasma PCSK9 Concentration as a Biomarker in Acute Coronary Syndrome. (PC-SCA-9)

Acute Coronary Syndrome

France
Nantes University Hospital

Completed

Anti-BK Virus Immune Response and Kidney Transplantation (BKv)

Kidney Transplantation

France
Institut de Recherches Cliniques de Montreal
McGill University

Withdrawn

Carbohydrates Under Target for Type 1 Diabetes Management

Type 1 Diabetes

Canada

Search clinical trials for: hepatic biological parameters

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Switzerland

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations